Загрузка...
Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
BACKGROUND: Recent evidence cautions against the use of non-selective beta-blockers (NSBB) in patients with refractory ascites or spontaneous bacterial peritonitis while other data suggests a survival benefit in patients with advanced liver disease. The aim of this study was to describe the use and...
Сохранить в:
| Опубликовано в: : | BMC Gastroenterol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945622/ https://ncbi.nlm.nih.gov/pubmed/31906860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-019-1155-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|